Cardinal Health Pharmaceutical and Specialty Solutions — Goodwill, Acquired During Period decreased by 100.5% to -$9.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.3%, from $3.42B to -$9.00M.
Higher values indicate aggressive inorganic growth and capital deployment into new business units.
The amount of goodwill recognized specifically from business acquisitions completed during the current reporting period...
Varies significantly based on the timing of M&A cycles within the pharmaceutical wholesale industry.
cah_segment_pharmaceutical_and_specialty_solutions_goodwill_acquired_during_period| Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $198.25M | $198.25M | $198.25M | $198.25M | $0.00 | $763.00M | $3.42B | $208.00M | $21.00M | $1.90B | -$9.00M |
| QoQ Change | — | — | — | — | — | +0.0% | +0.0% | +0.0% | -100.0% | — | +348.0% | -93.9% | -89.9% | >999% | -100.5% |
| YoY Change | — | — | — | — | — | — | — | — | -100.0% | +284.9% | >999% | +4.9% | — | +148.6% | -100.3% |